Statement of Changes in Beneficial Ownership (4)
23 Agosto 2021 - 6:41PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Cross Shawn |
2. Issuer Name and Ticker or Trading Symbol
Applied Molecular Transport Inc.
[
AMTI
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Financial Officer |
(Last)
(First)
(Middle)
C/O APPLIED MOLECULAR TRANSPORT INC., 1 TOWER PLACE, SUITE 850 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
8/19/2021 |
(Street)
SOUTH SAN FRANCISCO, CA 94080
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 8/19/2021 | | M | | 300 | A | $4.61 | 300 | D | |
Common Stock | 8/19/2021 | | S(1) | | 300 | D | $30.01 | 0 | D | |
Common Stock | 8/23/2021 | | M | | 9700 | A | $4.61 | 9700 | D | |
Common Stock | 8/23/2021 | | S(1) | | 9700 | D | $30.1227 (2) | 0 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to Buy) | $4.61 | 8/19/2021 | | M | | | 300 | 3/12/2021 (3) | 3/20/2030 | Common Stock | 300 | $0.00 | 309700 | D | |
Stock Option (Right to Buy) | $4.61 | 8/23/2021 | | M | | | 9700 | 3/12/2021 (3) | 3/20/2030 | Common Stock | 9700 | $0.00 | 300000 | D | |
Explanation of Responses: |
(1) | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on April 9, 2021. |
(2) | The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.97, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
(3) | 1/4th of the shares subject to the option became vested on the Exercisable Date and 1/48th of the shares subject to the option vest monthly thereafter, provided that the reporting person is a service provider to the issuer on each such vest date. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Cross Shawn C/O APPLIED MOLECULAR TRANSPORT INC. 1 TOWER PLACE, SUITE 850 SOUTH SAN FRANCISCO, CA 94080 |
|
| Chief Financial Officer |
|
Signatures
|
/s/ Brandon Hants Attorney-in-Fact for Shawn Cross | | 8/23/2021 |
**Signature of Reporting Person | Date |
Applied Molecular Transp... (NASDAQ:AMTI)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Applied Molecular Transp... (NASDAQ:AMTI)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024